| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
2 |
/ |
2023 |
|
|
|
| |
Data sporządzenia: |
2023-03-02 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
The registration of CompuFlo Epidural System with the U.S. Government's System for
Award Management _SAM_
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, "the Company", "the Issuer"_,
today announced that its CompuFlo Epidural System has been granted registration with
the U.S. Government's System for Award Management _"SAM"_. A SAM registration is required
for entities to bid on contracts and conduct business with federal government agencies,
including the Department of Defense, Department of Veterans Affairs, Indian Health
Service and other government agencies.
The Board of Directors of the Company is pleased to receive this SAM registration
for the CompuFlo Epidural System, which is required by all commercial entities to
sell products within the U.S. government. Given the safety benefits and efficiencies
associated with the instrument, the Board of Directors of the Company believes there
is a market opportunity within agencies such as the Department of Defense and the
Department of Veterans Affairs, where the CompuFlo system can contribute to improved
patient outcomes. This approval is an important step in the overall decision-making
and payment process. In addition, The Board of Directors of the Company is actively
pursuing U.S. Federal Supply Service _FSS_ approval for the CompuFlo Epidural Instrument
which, if granted, would provide uniform pricing across government agencies.
|
|
|
RB_ASO: The registration of CompuFlo Epidural System with the U.S. Government's System for
Award Management (SAM)
